MedPath

Research Progress of Electroacupuncture in Treating Chronic Atrophic Gastritis

Phase 1
Recruiting
Conditions
Chronic Atrophic Gastritis
Registration Number
ITMCTR2200006094
Lead Sponsor
anjing Hospital of Traditional Chinese Medicine affiliated to Nanjing University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. CAG patients who meet the above western diagnostic criteria; 2. Patients with liver and stomach qi stagnation syndrome according to the above TCM diagnostic criteria; 3. Hp negative confirmed by gastroscopy and pathological examination or Hp negative after eradication treatment; 4. Aged between 18 and 75, with no gender limitation; 5. Patients who did not receive acupuncture treatment or any medicine (Traditional Chinese medicine, Western medicine, patent Chinese medicine, etc.) for 14 consecutive days before inclusion; 6. Informed consent of patients should be obtained through communication, and patients should voluntarily and actively cooperate with diagnosis and treatment and other related research processes.

Exclusion Criteria

1. Unclear syndrome differentiation or too many other syndromes, inconsistent with the TCM diagnostic criteria involved in this study; 2. Patients with intraepithelial neoplasia or gastric cancer indicated by gastroscopy or pathological biopsy, metastasis of cancer cells or other systemic malignancies detected by imaging examination; 3. Those who have had previous stomach surgery; 4. Used traditional Chinese and Western medicine to treat the disease and influence the observation of curative effect within 3 months of the onset of this disease; 5. Patients with primary diseases such as serious damage to heart, brain, liver, kidney and hematopoietic system. People with cognitive, language or mental disabilities; 6. Women who are pregnant or planning to become pregnant and women who are breastfeeding; 7. Allergic constitution and those who are allergic to drugs needed in this study; 8. Within six months or are participating in other clinical trials.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Standard table of gastric mucosa grading and scoring under gastroscopy;Histopathological grading standard table;TCM syndrome integral record form;
Secondary Outcome Measures
NameTimeMethod
GEDPRO - CG scale;Follow-up investigation of recurrence rate;
© Copyright 2025. All Rights Reserved by MedPath